Next, potency of quisinostat-PPEG complexes was evaluated in WM115 human melanoma cell line, which is frequently used to evaluate both macromolecular drug delivery systems and HDAC inhibitors [36,37]. This evidence concerns the gene HDAC9 and melanoma.